Page last updated: 2024-08-26

tretazicar and Emesis

tretazicar has been researched along with Emesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, D; Baddeley, J; Chung-Faye, G; Clark, J; Downes, M; Ferry, D; Harris, PA; Hussain, S; Kerr, DJ; Murray, PI; Palmer, D; Searle, P; Seymour, L	1

Trials

1 trial(s) available for tretazicar and Emesis

Article	Year
Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:9 Topics: Abdominal Pain; Adenoviridae; Adult; Aged; Anorexia; Antineoplastic Agents; Aziridines; Diarrhea; Dose-Response Relationship, Drug; Fatigue; Female; Gastrointestinal Neoplasms; Genetic Vectors; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Middle Aged; Nausea; Nitroreductases; Prodrugs; Treatment Outcome; Vomiting	2001

Article

Year

Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:9

Topics: Abdominal Pain; Adenoviridae; Adult; Aged; Anorexia; Antineoplastic Agents; Aziridines; Diarrhea; Dose-Response Relationship, Drug; Fatigue; Female; Gastrointestinal Neoplasms; Genetic Vectors; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Middle Aged; Nausea; Nitroreductases; Prodrugs; Treatment Outcome; Vomiting

2001